期刊文献+

不同血液净化方式对维持性血液透析患者血清炎症因子的影响 被引量:8

Effects of Different Blood Purification Methods on Serum Inflammatory Cytokine in Maintenance Hemodialysis Patients
暂未订购
导出
摘要 目的观察低通量血液透析(LFHD)、高通量血液透析(HFHD)和血液透析滤过(HDF)对维持性血液透析(MHD)患者血清炎症因子的影响。方法选取MHD患者60例,随机分为LFHD组、HFHD组和HDF组各20例,对照组为20名健康体检者,检测透析前后及透析6月血清CRP、IL-6、IL-8及TNF?α水平。结果 MHD患者透析前血清CRP、IL-6、IL-8及TNF?α水平高于对照组(P<0.01)。LFHD组单次和透析6个月后CRP、IL-6、IL-8及TNF?α水平均不降低(P>0.05);HFHD组单次透析后CRP、IL-6、IL-8及TNF?α水平下降不明显(P>0.05),透析6个月后,CRP、IL-6、IL-8及TNF?α水平下降(P<0.05);HDF组单次和透析6个月后CRP、IL-6、IL-8及TNF?α水平下降(P<0.05);透析6个月后,HDF组CRP、IL-6、IL-8及TNF?α水平低于HFHD组同期水平(P<0.05)。结论 MHD患者存在着微炎症状态,HDF和HFHD透析可以降低血清CRP、IL-6、IL-8及TNF?α水平,改善MHD患者微炎症状态,HDF透析优于HFHD。 Objective To study the effects of low-flux hemodia|ysis (LFHD), high-flux hemodialysis (HFHD and hemodiafihration (HDF) on the serum inflammatory cytokine in maintenance hemodialysis (MHD) patients. Methods Sixty MHD patients were randomly divided into LFHD group, HFHD group and HDF grouF Results The levels of serum CRP, IL-6, IL-8 and TNF-α were detected in three groups and control grouF The results showed that levels of CRP, IL-6, IL-8 and TNF -α in patients with MHD before treatment were muc higher than these in control group (P 〈0.01 ). The levels of CRP, IL-6, IL-8 and TNF~ did not significantl decrease in patients with LFHD after the first hemodialysis and after the hemodialysis 6 months ( P 〉 0.05 ) The levels of CRP, IL-6, IL-8 and TNF-αdid not significantly decrease in patients with HFHD after the fir hemodialysis (P 〉0.05). The levels of CRP, IL45, IL-8 and TNF-α decreased markedly in patients with Hi HD after 6 months hemodialysis(P 〈0.05 ). The levels of CRP, IL-6, IL-8 and TNF-α decreased significant in patients with HDF after the first hemodialysis and after 6 months(P 〈0.05). The levels of CRP, IL-6, IL- 8 and TNF-α in HDF group were significantly lower than those in HFHD group after 6 months ( P 〈 0.05 ) Conclusion There was microinflammatory state in MHD patients. The lowering of patients'serum CRP, IL-6 IL-8 and TNF-α levels and thus the recovery from microinflammatory state may be achieved by HDF, HFHD-α and HFHD preferably by HDF.
出处 《标记免疫分析与临床》 CAS 2012年第1期17-20,共4页 Labeled Immunoassays and Clinical Medicine
关键词 血液透析 低通量血液透析 高通量血液透析 血液透析滤过 微炎症状态 炎症因子 Hemodialysis Low-flux hemodialysis High-flux hemodialysis Hemodiafiltration Microin-flammation Inflammatory cytokine
  • 相关文献

参考文献8

  • 1Zoccali C,Mallamaci F,Tripepi G.Novel cardiovascular risk factors in end-stage renal disease[J].J Am Soc Nephrol,2004,15(Suppl 1):S77-S80.
  • 2George A.The microinflammatory state in uremia causes and poten-tial consequences[J].J Am Soc Nephrol,2001,12(7):1549-1557.
  • 3徐妍,刘必成,尹莲芳.血液透析患者体内的炎症反应状态及其意义[J].中国血液净化,2003,2(3):148-150. 被引量:5
  • 4Arici M,Walls J.End-stage renal disease,atherosclerosis,and car-diovascular mortality:is C-reactive protein the missing link?[J].Kidney Int,2001,59:407-414.
  • 5Tzoulaki I,Murray G D,Lee A J,et al.C-reactive protein,interleu-kin-6,and soluble adhesion molecules as predictors of progressive pe-ripheral atherosclerosis in the general population Edinburgh Artery Study[J].Circulation,2005,112(7):976-983.
  • 6Yudkin J S,Kumari M,Humphries S E,et al.Imflammation,obesi-ty,stress and coronary heart disease:Is interleukin-6the link?[J].Atherosclerosis,2000,148:209-214.
  • 7叶朝阳.高通量血液透析的临床应用体会[J].肾脏病与透析肾移植杂志,2005,14(3):251-252. 被引量:32
  • 8Filiopoulos V,Hadjiyannakos D,Metaxaki P,et al.Inflammation and oxidative stress in patients on hemodiafiltration[J].Am J Neph-rol,2008,28:949-957.

二级参考文献18

  • 1[1]Patrick L, Uzick M. Cardiovascular disease: C-reactive protein and the inflammatory disease paradigm: HMG-CoA reductase inhibitors, alpha-tocopherol, red yeast rice, and olive oil polyphenols. A review of the literature. Altern Med Rev, 2001, 6(3): 248
  • 2[2]Panichi V, Migliori M, De Pietro S, et al. The link of biocompatibility to cytokine production. Kidney Int, 2000, 58 Suppl 76S96
  • 3[3]Panichi V, Migliori M, De Pietro S, et al. C-reactive protein as a marker of chronic inflammation in uremic patients. Blood Purif, 2000, 18(3): 183
  • 4[4]Arici M, Walls J. End-stage renal disease, atherosclerosis, and cardiovascular mortality: is C-reactive protein the missing link? Kidney Int, 2001, 59(2): 407
  • 5[5]Kaysen GA.The microinflammatory state in uremia: causes and potential consequences. J Am Soc Nephrol, 2001, 12(7): 1549
  • 6[6]Lonnemann G.Chronic inflammation in hemodialysis:the role of contaminated dialysate. Blood Purif, 2000, 18(3): 214
  • 7[7]Schindler R,Boenisch O,Fischer C, et al. Effect of the hemodialysis membrane on the inflammatory reaction in vivo. Clin Nephrol, 2000, 53(6): 452
  • 8[8]Shimoike T, Inoguchi T, Umeda F, et al. The meaning of serum levels of advanced glycosylation end products in diabetic nephropathy. Metabolism, 2000, 49(8): 1030
  • 9[9]Liu Nai Feng,SUN Zi Lin,LIU Bi Cheng. Clearance of increased serum advanced glycosylation end products in patients with end stage renal disease by hemodialysis. Acta Pharmacol Sin, 2000, 21(3): 276
  • 10[10]Schwenger V, Zeier M, Henle T, et al. Advanced glycation endproducts (AGEs) as uremic toxins. Nephron, 2001, 45(3): 172

共引文献34

同被引文献59

  • 1王剑青,邓安国,戴勇.血液透析与微炎症状态[J].国外医学(泌尿系统分册),2005,25(4):503-506. 被引量:6
  • 2杨明正,张小如,邹毓媚,廖益飞.伊贝沙坦联合辛伐他汀对维持性血液透析患者微炎症状态的影响[J].现代中西医结合杂志,2006,15(17):2318-2319. 被引量:2
  • 3社区获得性肺炎诊断和治疗指南[J].中华结核和呼吸杂志,2006,29(10):651-655. 被引量:3113
  • 4Zhang Jianrong, Li Xiaoping, Zhang Yanxia, et al.Blood perfusion improve micro inflammation in patients with secondary near a port state of clinical research [J]. Journal of third military medical university, 2012, 35 ( 17 ) : 1786-1789.
  • 5Souza CM,Braosi AP,Luczyszyn SM. Oral health in Brazilian patients with chronic renal disease[J].{H}Revista Medica de Chile,2008.741-746.
  • 6Craig RG. Interactions between chronic renal disease and periodontal dis-ease[J].{H}ORAL DISEASES,2008.1-7.
  • 7Bayraktar G,Kurtulus I,Duraduryan A. Dental and periodontal find-ings in hemodialysis patients[J].{H}ORAL DISEASES,2007.393-397.
  • 8Sobrado Marinho JS,Tomás Carmona I,Loureiro A. Oral health sta-tus in patients with moderate-severe and terminal renal failure[J].Med Oral Patol Oral Cir Bucal,2007.E305-E310.
  • 9Bhimma R.Steroid Sensitive Nephrotic Syndrome in Children[J].J Nephrol Therapeutic S,2014,11:2161-0959.
  • 10Shalhoub RJ.Pathogenesis of lipoid nephrosis:a disorder of T-cell function[J].The Lancet,1974,2(7880):556-560.

引证文献8

二级引证文献26

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部